On May 25, Beijing time, Immunity, a leading international journal of immunology, published the latest results of the collaboration between the Gulou Hospital Affiliated to the School of Medicine of Nanjing University and the Institute of Modern Biology of Nanjing University. The research team led b......

On June 1, 2021, CTI Biopharma announced that the U.S. Food and Drug Administration has accepted its New Drug Application (NDA) for pacritinib, an oral kinase inhibitor in the pipeline, to treat myelofibrosis, a disease associated with severe thrombocytopenia. The FDA also granted priority review st......

The inactivated Coronavirus vaccine independently developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences (hereinafter referred to as the Institute of Biology, Chinese Academy of Medical Sciences) is the first batch of Coronavirus inactivated vaccine marketed for emergency......

Multiple clinical trials and real-world studies have shown that the COVID-19 vaccine provides effective protection against COVID-19 in recipients. The other goal of mass vaccination is "herd immunity," which means that when a sufficient percentage of the population becomes immune from the vaccine (o......

Titanium dioxide products produced by Panzhihua Iron and Steel Co., Ltd are of stable quality. Products such as R-298, R-248 and R-5566 have been widely recognized in the global market and have been sold to many countries in Europe, Asia Pacific, Middle East and so on. If you have any demand for tit......

Researchers have found that an antibiotic known as novobiocin (NVB), discovered in the 1950s, is effective in killing tumor cells that carry defects in homologous recombinant (HR) DNA repair. This ability to kill is also effective against tumor cells that have acquired resistance to the poly (ADP) r......